Baxter
BAX
#1211
Rank
NZ$26.31 B
Marketcap
$51.54
Share price
0.75%
Change (1 day)
-16.49%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$46.38 Billion

According to Baxter's latest financial reports the company's total assets are NZ$46.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Baxter - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$44.71 B0.36%
2022-12-31NZ$44.55 B-9.22%
2021-12-31NZ$49.07 B76.88%
2020-12-31NZ$27.74 B2.71%
2019-12-31NZ$27.01 B15.27%
2018-12-31NZ$23.43 B-2.73%
2017-12-31NZ$24.09 B7.35%
2016-12-31NZ$22.44 B-26.72%
2015-12-31NZ$30.62 B-8.19%
2014-12-31NZ$33.35 B8.68%
2013-12-31NZ$30.69 B23.84%
2012-12-31NZ$24.78 B1.42%
2011-12-31NZ$24.43 B7.8%
2010-12-31NZ$22.66 B-5.12%
2009-12-31NZ$23.89 B-9.99%
2008-12-31NZ$26.54 B32.95%
2007-12-31NZ$19.96 B-4.22%
2006-12-31NZ$20.84 B11.95%
2005-12-31NZ$18.62 B-6.08%
2004-12-31NZ$19.82 B-5.98%
2003-12-31NZ$21.08 B-11.56%
2002-12-31NZ$23.84 B-4.28%
2001-12-31NZ$24.90 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$74.87 B 61.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$76.22 B 64.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$66.21 B 42.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$99.62 B 114.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.68 B-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$174.53 B 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.83 B-80.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$156.58 B 237.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$7.48 B-83.86%๐Ÿ‡บ๐Ÿ‡ธ USA